Candida overgrowth (candidiasis) is a dysbiotic condition in which Candida albicans, a commensal yeast of the gastrointestinal, oropharyngeal, and urogenital tracts, proliferates to pathological levels following disruption of the intestinal microbiome, immune suppression, or metabolic imbalance
The FDA removed semaglutide from the drug shortage list in February 2025 and tirzepatide in October 2024, which restricted 503B outsourcing facilities from large-scale compounding
The maintenance dose of WEGOVY is 2.4 mg once weekly OZEMPIC does NOT have a 1.7mg or 2.4mg dosing prefilled pen
Not all products are created equal
Climb only when your results have genuinely stalled and your body is telling you it can handle more
doi:10.1001/jamainternmed.2024.4661